Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | REPL | OCGN | ||
| Company | Lexicon Pharmaceutcl | Replimune Group Inc | Ocugen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.6300 | 7.25 | 1.7500 | ||
| High | 1.6600 | 7.41 | 2.0000 | ||
| Low | 1.5700 | 7.17 | 1.7200 | ||
| Latest | 1.6300 | 7.25 | 1.9600 | ||
| Change | +0.0200 | +0.08 | +0.1000 | ||
| % Change | +1.24% | +1.12% | +5.38% | ||
| Volume | 2,503,700 | 735,700 | 12,079,200 | ||
| 20-Day Average Volume | 2,490,270 | 1,287,550 | 5,419,595 | ||
| Previous Close | 1.6100 | 7.17 | 1.8600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4035 | 7.77 | 1.5970 | ||
| 20-Day Raw Stochastic | 93.88% | 23.04% | 94.20% | ||
| 20-Day Relative Strength | 60.42 | 43.00 | 65.12 | ||
| Weighted Alpha | +229.75 | +1.12 | +166.02 | ||
| Today's Opinion | 88% Buy | 48% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 48% Sell | 100% Buy | ||
| Last Month's Opinion | 16% Buy | 56% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.67% since 02/25/26 | -11.59% since 02/25/26 | +5.38% since 02/25/26 | ||
| Low | 1.4200 on 03/02/26 | 6.79 on 03/03/26 | 1.6600 on 03/02/26 | ||
| High | 1.6600 on 03/04/26 | 8.35 on 02/26/26 | 2.0000 on 03/04/26 | ||
| 1-Month | |||||
| %Chg | +28.35% since 02/04/26 | +3.57% since 02/04/26 | +39.01% since 02/04/26 | ||
| Low | 1.1700 on 02/09/26 | 6.78 on 02/05/26 | 1.3100 on 02/09/26 | ||
| High | 1.6600 on 03/04/26 | 8.82 on 02/23/26 | 2.0000 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | +14.79% since 12/04/25 | -31.15% since 12/04/25 | +58.06% since 12/04/25 | ||
| Low | 1.1000 on 01/30/26 | 6.77 on 01/20/26 | 1.1800 on 12/08/25 | ||
| High | 1.8300 on 01/22/26 | 11.09 on 12/08/25 | 2.0000 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +52.34% since 09/04/25 | +24.78% since 09/04/25 | +90.29% since 09/04/25 | ||
| Low | 1.0500 on 09/08/25 | 3.12 on 09/22/25 | 1.0100 on 09/09/25 | ||
| High | 1.8300 on 01/22/26 | 11.26 on 12/02/25 | 2.0000 on 03/04/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 585,180 | 592,048 | 580,915 | ||
| Shares Outstanding, K | 363,466 | 82,573 | 312,320 | ||
| Annual Sales | 31,080,000 | 0 | 4,060,000 | ||
| Annual Net Income | -200,400,000 | -247,300,000 | -54,050,000 | ||
| Last Quarter Sales | 14,180,000 | 0 | 1,750,000 | ||
| Last Quarter Net Income | -12,770,000 | -70,930,000 | -20,050,000 | ||
| 60-Month Beta | 0.94 | 0.72 | 2.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 11/06/25 | -0.90 on 11/06/25 | -0.07 on 11/05/25 | ||
| Latest Earnings Date | 03/05/26 | 05/28/26 | 03/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||